232 related articles for article (PubMed ID: 36723483)
21. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a C-Terminal SUMO-Interacting Motif Present in Select PIAS-Family Proteins.
Lussier-Price M; Mascle XH; Cappadocia L; Kamada R; Sakaguchi K; Wahba HM; Omichinski JG
Structure; 2020 May; 28(5):573-585.e5. PubMed ID: 32348746
[TBL] [Abstract][Full Text] [Related]
23. A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.
Depaux A; Regnier-Ricard F; Germani A; Varin-Blank N
Oncogene; 2007 Oct; 26(46):6665-76. PubMed ID: 17533377
[TBL] [Abstract][Full Text] [Related]
24. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
[TBL] [Abstract][Full Text] [Related]
25. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.
Morris JR; Boutell C; Keppler M; Densham R; Weekes D; Alamshah A; Butler L; Galanty Y; Pangon L; Kiuchi T; Ng T; Solomon E
Nature; 2009 Dec; 462(7275):886-90. PubMed ID: 20016594
[TBL] [Abstract][Full Text] [Related]
26. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
Nishida T; Yasuda H
J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
[TBL] [Abstract][Full Text] [Related]
27. Multiple domains in Siz SUMO ligases contribute to substrate selectivity.
Reindle A; Belichenko I; Bylebyl GR; Chen XL; Gandhi N; Johnson ES
J Cell Sci; 2006 Nov; 119(Pt 22):4749-57. PubMed ID: 17077124
[TBL] [Abstract][Full Text] [Related]
28. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
[TBL] [Abstract][Full Text] [Related]
29. Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation.
Van Dyck F; Delvaux EL; Van de Ven WJ; Chavez MV
J Biol Chem; 2004 Aug; 279(34):36121-31. PubMed ID: 15208321
[TBL] [Abstract][Full Text] [Related]
30. Global Identification of Small Ubiquitin-related Modifier (SUMO) Substrates Reveals Crosstalk between SUMOylation and Phosphorylation Promotes Cell Migration.
Uzoma I; Hu J; Cox E; Xia S; Zhou J; Rho HS; Guzzo C; Paul C; Ajala O; Goodwin CR; Jeong J; Moore C; Zhang H; Meluh P; Blackshaw S; Matunis M; Qian J; Zhu H
Mol Cell Proteomics; 2018 May; 17(5):871-888. PubMed ID: 29438996
[TBL] [Abstract][Full Text] [Related]
31. Pli1(PIAS1) SUMO ligase protected by the nuclear pore-associated SUMO protease Ulp1SENP1/2.
Nie M; Boddy MN
J Biol Chem; 2015 Sep; 290(37):22678-85. PubMed ID: 26221037
[TBL] [Abstract][Full Text] [Related]
32. HIF-1α SUMOylation affects the stability and transcriptional activity of HIF-1α in human lens epithelial cells.
Han X; Wang XL; Li Q; Dong XX; Zhang JS; Yan QC
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1279-90. PubMed ID: 25877955
[TBL] [Abstract][Full Text] [Related]
33. Chordate PIAS proteins act as conserved repressors of the TRAF6 self-polyubiquitination.
Fu X; Wang R; Li M; Yan X; Huang H; Li J; Chen S; Yue Z; Chen S; Li Y; Dong M; Xu A; Huang S
Dev Comp Immunol; 2020 Mar; 104():103554. PubMed ID: 31758961
[TBL] [Abstract][Full Text] [Related]
34. Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins.
Kim J; Sharma S; Li Y; Cobos E; Palvimo JJ; Williams SC
J Biol Chem; 2005 Apr; 280(13):12246-54. PubMed ID: 15661739
[TBL] [Abstract][Full Text] [Related]
35. Dynamin interacts with members of the sumoylation machinery.
Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
[TBL] [Abstract][Full Text] [Related]
36. Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.
Lara-Ureña N; Jafari V; García-Domínguez M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887358
[TBL] [Abstract][Full Text] [Related]
37. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
Schmidt D; Müller S
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
[TBL] [Abstract][Full Text] [Related]
38. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
[TBL] [Abstract][Full Text] [Related]
39. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
[TBL] [Abstract][Full Text] [Related]
40. Identification of SUMO E3 ligase-specific substrates using the HuProt human proteome microarray.
Cox E; Uzoma I; Guzzo C; Jeong JS; Matunis M; Blackshaw S; Zhu H
Methods Mol Biol; 2015; 1295():455-63. PubMed ID: 25820740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
